US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry.
about
Incidence and prevalence of inflammatory myopathies: a systematic reviewFamilial aggregation of autoimmune disease in juvenile dermatomyositisValidation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of diseaseDuration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.On Determining the Effects of Therapy on Disease Damage in Non- randomized Studies with Multiple Treatments: A study of Juvenile Myositis.Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis.Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance RegistryDeveloping a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research.Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference.Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral bloodDermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.Acute acalculous cholecystitis in a patient with juvenile dermatomyositisJuvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.Vascular and connective tissue diseases in the paediatric world.The heterogeneity of juvenile myositisBeyond the MHC: A canine model of dermatomyositis shows a complex pattern of genetic risk involving novel loci.Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.Intersection of inflammation and herbal medicine in the treatment of osteoarthritisApoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease.Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is UnderestimatedIs juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center's experience.MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositisAdult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Sex-specific genetic architecture of human disease.Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study.Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional studyChildhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.Acute Presentation of Juvenile Dermatomyositis with Subclinical Cardiac Involvement: A Rare Case.Mycophenolate mofetil in juvenile dermatomyositis: a case series.Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.Clinical features and disease course of patients with juvenile dermatomyositis.Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis.
P2860
Q26999366-F95D6FD7-F081-48F3-A8D0-650CD914FFC3Q28235854-50AAF1C2-D996-47EC-8B05-2578E9C2FEE5Q28652726-B1197869-BEF5-4AEA-ABB2-F668F0BD3760Q33356785-3E351EB7-F5EB-4615-A2F3-0F8A8AD4C235Q33694683-94E5CA4F-0A89-4ADD-A430-839E28929A0FQ33704375-00E12954-A487-4583-8376-18821C8C8E8AQ33717793-C0123755-C3E2-4CE9-957A-CBE4B6C49AA5Q33779452-43D74127-5208-47F7-9867-041BFF9AD23DQ33834285-B884BAD6-1B69-4FF8-A10C-525B50F3570BQ33962448-63A5CD66-E2EF-4E27-985C-25A2BEA3C537Q34019438-A685FAEA-FB73-422C-80C5-900452F9FF69Q34089662-9C341E33-AC37-43B1-89E7-414F9EE806C4Q34140461-165243EE-7E4E-4395-819B-9E4F644C7528Q34185599-5750EC82-3875-40B5-945A-5668520D3A35Q34220104-A83B2517-C431-4F13-BD91-E641B3E0B9EFQ35009335-E35BC2E7-EC7F-46A9-A21B-80962338A9F2Q35184886-AE209E5B-A089-4B9C-BF9E-F084B26D805DQ35680229-9CA813CE-C9D6-482F-A218-57B34705D925Q35748264-891FACC1-2FAD-408C-88CD-5CE3EE0C9F58Q36269554-9E755ADE-E3F8-4DC3-889B-C8EB79EF55B5Q36312962-53566A0F-CC13-42E4-815C-7E3C903339DCQ36346952-B2B64450-D87C-461A-B4F3-3879A96E957FQ36417352-8D8DE01A-04E5-4ED3-AA39-535FE46C4A41Q36498667-2DCE1195-278E-4C87-B21D-6BDBAD520BA8Q36532789-897E0750-36A1-40AF-B921-8D90657FF803Q36689941-AAAFCC48-069E-46C8-BFC1-FAC8CBDFACF3Q36794029-7D5D3319-AD56-40AA-AD9A-FF0BE5928437Q36903076-C04C4E04-839D-4CC4-8836-2E5D1D9DE1A6Q37223066-8A34A2A3-7961-4CC1-90CF-17EE834ABE48Q37240498-B1ACF32A-108A-4108-9844-44403FBBA17CQ37368405-9FC56B8D-265D-4DDE-B694-145B648FD2E7Q37410392-BCCD851E-EBB7-4844-BDDF-C607BD3C0237Q37497903-7CB478CA-B41A-4AC8-9D10-DDF8898E1C19Q37579105-A53EA249-2E6E-41B4-9E25-7825396DFB67Q37630165-9359D3E0-F3A0-46C4-B361-68E27FC955ACQ37820306-F0A2EF95-7E6D-4BCB-840B-B1448251A211Q37906737-DFFC9FB2-6333-4D0D-95F4-A29FC9060692Q37938701-24CA07CF-D0CC-46B5-A6E4-F4742DCC2CC3Q38155955-9D392159-D30C-4960-85F3-B171EBD776B8Q38216182-A57A368F-413F-43A4-9F65-2862D760DE15
P2860
US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@en
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@nl
type
label
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@en
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@nl
prefLabel
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@en
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@nl
P2093
P356
P1476
US incidence of juvenile derma ...... al and Skin Diseases Registry.
@en
P2093
Eduardo P Mendez
Lauren M Pachman
NIAMS Juvenile DM Registry Physician Referral Group
Phil Roettcher
Rebecca Lipton
Rosalind Ramsey-Goldman
Susan Bowyer
P304
P356
10.1002/ART.11122
P577
2003-06-01T00:00:00Z